Liver transplantation for primary biliary cirrhosis

James Neuberger

Research output: Contribution to journalReview article

34 Citations (Scopus)


Liver transplantation is now the accepted treatment for patients with end-stage disease or intractable symptoms. The success rate is high. Those grafted for PBC are at greater risk of developing acute and chronic rejection and are less likely to be weaned from immunosuppression. Following transplantation, AMA persist and histological features of PBC may be seen in the allograft, in up to 50% by 10 years.
Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalAutoimmunity Reviews
Issue number1
Publication statusPublished - 1 Jan 2003


Dive into the research topics of 'Liver transplantation for primary biliary cirrhosis'. Together they form a unique fingerprint.

Cite this